Literature DB >> 16147542

Clinical transplantation: current problems, possible solutions.

Roy Calne1.   

Abstract

I have attempted to summarize the progress that has been made in organ transplantation in the past 50 years since the first identical twin transplant. For those who have worked long in this area its success has been remarkable. We currently expect patients to survive the operation and more than 90% of the graft to be functioning at a year with the half-life of the graft beyond 10 years, with some patients surviving into the fifth decade after kidney transplantation with grafts from unrelated donors and the fourth decade for liver transplants. Now the main stumbling block is shortage of organ donors and this is unlikely to be solved easily. There has been a considerable increase in donations from living volunteers and also the worry of immoral and illegal practices. In the future, we can expect considerable advances in immunosuppression with more effective, less toxic drugs and in some patients induction therapy that may approach tolerance so that no maintenance therapy will eventually be needed. Cell transplantation is likely to be developed as treatment for the clinic in the next 5-10 years, but developments of transplantation from animal to man still remains unsolved and unlikely to be successful in the clinic in the near future.

Entities:  

Mesh:

Year:  2005        PMID: 16147542      PMCID: PMC1569533          DOI: 10.1098/rstb.2005.1708

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  11 in total

1.  RENAL HETEROTRANSPLANTATION IN MAN.

Authors:  K REEMTSMA; B H MCCRACKEN; J U SCHLEGEL; M A PEARL; C W PEARCE; C W DEWITT; P E SMITH; R L HEWITT; R L FLINNER; O CREECH
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  Renal homotransplantation in identical twins.

Authors:  J H HARRISON; J P MERRILL; J E MURRAY
Journal:  Surg Forum       Date:  1956

3.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

4.  The fate of skin homografts in man.

Authors:  T Gibson; P B Medawar
Journal:  J Anat       Date:  1943-07       Impact factor: 2.610

5.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

Review 6.  Induction of transplantation tolerance in non-human primate preclinical models.

Authors:  Douglas A Hale; Kiran Dhanireddy; David Bruno; Allan D Kirk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 7.  Development of tolerogenic strategies in the clinic.

Authors:  Stuart J Knechtle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

8.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

9.  Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.

Authors:  Martin Wijkstrom; Norma S Kenyon; Nicole Kirchhof; Norman M Kenyon; Claudy Mullon; Philip Lake; Sylvain Cottens; Camillo Ricordi; Bernhard J Hering
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

10.  Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis.

Authors:  A C Farney; J S Najarian; R E Nakhleh; G Lloveras; M J Field; P F Gores; D E Sutherland
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

View more
  3 in total

1.  Introduction: immunoregulation: harnessing T cell biology for therapeutic benefit.

Authors:  Su M Metcalfe; Roy Y Calne; Stephen P Cobbold
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

2.  A biodegradable and biocompatible PVA-citric acid polyester with potential applications as matrix for vascular tissue engineering.

Authors:  Lynda V Thomas; U Arun; S Remya; Prabha D Nair
Journal:  J Mater Sci Mater Med       Date:  2008-10-16       Impact factor: 3.896

3.  (Citric acid-co-polycaprolactone triol) polyester: a biodegradable elastomer for soft tissue engineering.

Authors:  Lynda V Thomas; Prabha D Nair
Journal:  Biomatter       Date:  2011 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.